Skip to main content
Meta navigation
Contact
Donate
Jobs
Main navigation
For patients
For researchers
About us
Network
Breast cancer
5 currently open clinical trials
Surgical lymph node removal with the option of “extensive operation” or “radiotherapy” in breast cancer patients with existing axillary lymph node involvement
SAKK 23/16 TAXIS
Palbociclib for patients with hormone receptor positive / HER2-negative breast cancer that has recurred after surgical removal (POLAR)
IBCSG 59-19 POLAR
Breast cancer: is surgery still necessary if tumor tissue can no longer be detected following chemotherapy?
SAKK 23/18 - VISION I
Researchers are looking for a better way to treat ER+/HER2- early-stage breast cancer
CAMBRIA-2
Triple-negative (hormone-independent) breast cancer, TNBC
SAKK 66/22
All cancer types
Concluded trials
Eribulin as first-line chemotherapy in advanced breast cancer for patients over 70 years
SAKK 25/14
Mobile main navigation
For patients
For patients
Participate in a trial
Genetic Counseling
FAQ
Glossary
Downloads
For researchers
For researchers
Research groups
Young Oncology Academy
Grants and fellowships
Electronic Data Capture (EDC)
About us
About us
Mission statement
Organization
SAKK Board
Scientific Committee
Directors' Committee
Executive Committee and Extended Executive Committee
Patient Advisory Board
Support and collaborations
Media and publications
Network
Mobile meta navigation
Contact
Donate
Jobs
Vacancies
Work for us
Our values
Work–life balance
Wages and benefits
Staff development
Mobile footer navigation
Imprint
Privacy Policy
Disclaimer
EN
DE
FR
Mobile quicklinks
Trials
Events
News
Portal
Quicklinks
Trials
Events
News
Portal